High density lipoproteins and ischemia reperfusion injury: the therapeutic potential of HDL to modulate cell survival pathways (Q38231258)

31 August 2017

title

High density lipoproteins and ischemia reperfusion injury: the therapeutic potential of HDL to modulate cell survival pathways (English)

1 reference

31 August 2017

1 reference

Richard W James

1

1 reference

31 August 2017

Miguel A Frias

series ordinal

2

1 reference

31 August 2017

language of work or name

English

0 references

publication date

1 January 2014

1 reference

Advances in Experimental Medicine and Biology

31 August 2017

published in

1 reference

31 August 2017

volume

824

1 reference

31 August 2017

page(s)

19-26

1 reference

Effects of dalcetrapib in patients with a recent acute coronary syndrome

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/978-3-319-07320-0_3

High density lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-07320-0_3

High-density lipoproteins. Multifunctional but vulnerable protections from atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-07320-0_3

Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-07320-0_3

Unraveling the complexities of the HDL lipidome

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-07320-0_3

HDLs protect pancreatic β-cells against ER stress by restoring protein folding and trafficking

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-07320-0_3

High-density lipoprotein maintains skeletal muscle function by modulating cellular respiration in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-07320-0_3

High density lipoprotein mediated lipid efflux from retinal pigment epithelial cells in culture

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-07320-0_3

Significance of apolipoproteins for structure, function, and classification of plasma lipoproteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-07320-0_3

Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-07320-0_3

Signalling pathways in ischaemic postconditioning.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-07320-0_3

Preconditioning and postconditioning: underlying mechanisms and clinical application.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-07320-0_3

High-density lipoprotein cholesterol and prognosis after myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-07320-0_3

Ischemia-reperfusion arrhythmias and lipids: effect of human high- and low-density lipoproteins on reperfusion arrhythmias

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-07320-0_3

High-density lipoproteins protect isolated rat hearts from ischemia-reperfusion injury by reducing cardiac tumor necrosis factor-alpha content and enhancing prostaglandin release

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-07320-0_3

Synthetic high-density lipoproteins exert cardioprotective effects in myocardial ischemia/reperfusion injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-07320-0_3

Apolipoprotein A-IMilano/POPC complex attenuates post-ischemic ventricular dysfunction in the isolated rabbit heart

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-07320-0_3

High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-07320-0_3

Anti-atherogenic effects of high-density lipoprotein on nitric oxide synthesis in the endothelium

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-07320-0_3

Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1/2: role of sphingosine-1-phosphate

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-07320-0_3

Native and reconstituted HDL protect cardiomyocytes from doxorubicin-induced apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-07320-0_3

High-density lipoprotein determines adult mouse cardiomyocyte fate after hypoxia-reoxygenation through lipoprotein-associated sphingosine 1-phosphate

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-07320-0_3

Myocardial ischemia-reperfusion injury: a neglected therapeutic target.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-07320-0_3

When are pro-inflammatory cytokines SAFE in heart failure?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-07320-0_3

Regulation of signal transduction by HDL.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-07320-0_3

Sphingolipid signalling in the cardiovascular system: good, bad or both?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-07320-0_3

Activation of Pak1/Akt/eNOS signaling following sphingosine-1-phosphate release as part of a mechanism protecting cardiomyocytes against ischemic cell injury.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-07320-0_3

Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-07320-0_3

HDL protects against ischemia reperfusion injury by preserving mitochondrial integrity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-07320-0_3

Cardioprotection: nitric oxide, protein kinases, and mitochondria

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-07320-0_3

Biomedicinal implications of high-density lipoprotein: its composition, structure, functions, and clinical applications

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-07320-0_3

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-07320-0_3

Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-07320-0_3

High-density lipoprotein restores endothelial function in hypercholesterolemic men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-07320-0_3

Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-07320-0_3

Apolipoprotein A-IMilano and 1-palmitoyl-2-oleoyl phosphatidylcholine complex (ETC-216) protects the in vivo rabbit heart from regional ischemia-reperfusion injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-319-07320-0_3

10.1007/978-3-319-07320-0_3

31 March 2020

Identifiers

DOI

1 reference

31 August 2017

1 reference